Tech Company Financing Transactions
Actio Biosciences Funding Round
Actio Biosciences, operating out of San Diego, secured $55 million from Canaan Partners, Droia Ventures and Deerfield Management Company.
Transaction Overview
Company Name
Announced On
9/14/2023
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series A
Investors
Canaan Partners (Lead Investor)
Droia Ventures (Lead Investor)
Proceeds Purpose
Actio is leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases. The company's platform comprises a vast proprietary target database, called the Rare Disease Target Atlas, and expertise in bioinformatics, biology and chemistry.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9310 Athena Circle 100
San Diego, CA 92037
USA
San Diego, CA 92037
USA
Phone
Undisclosed
Website
Email Address
Overview
Actio was founded by leaders in genetics and drug development to push the boundaries of how we translate genetic insights into new medicines. Actio is more than a precision medicine company -- we have a bold vision to take learnings in how we pinpoint targets and develop drugs for homogenous rare disease populations and leverage those learnings to identify underlying biology in heterogenous common disease populations. Through our unique approach, we aim to bring meaningful new therapeutics from one to many.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Chief Executive Officer
David Goldstein
Chief Scientific Officer
David Breckenridge
Co-Founder
John McHutchison
Browse more venture capital transactions:
Prev: 9/14/2023: EquipmentShare venture capital transaction
Next: 9/14/2023: Flipto venture capital transaction
Share this article
News on VC Transactions
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs